Business Standard·· 5 天前AI 评分15
Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo
Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo
利好+0.62对 相关个股影响 中等
专利障碍解除有助于生物类似药商业化
stock_ai_django 新闻打标（gpt-6-luna），方向针对资产价格，不是本站判断，也不构成投资建议
AI 导读
Genentech patent settlement clears legal hurdles for Pebrilzo; competition and pricing will determine commercial gains
来源：Business Standard · business-standard.com